This site is intended for Healthcare professionals only.

Suven Life gets product patents from India, S. Korea and Singapore


Suven Life gets product patents from India, S. Korea and Singapore

New Delhi: Suven Life Sciences said it has been granted a product patent by India, Singapore, South Korea and Israel each for a new chemical entity (NCE) used in the treatment of disorders associated with neurodegenerative diseases.

These patents are valid through 2031, 2034, 2034 and 2036 respectively, the company said in a BSE filing.

“We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally,” Suven Life CEO Venkat Jasti said.

The granted claims of patents are being developed as therapeutic agents useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), Huntington’s disease, Parkinson’s and schizophrenia, it added.



Source: PTI
0 comment(s) on Suven Life gets product patents from India, S. Korea and Singapore

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted